Case Reports Hepatology forum. 2021 Sep 15;2(3):117-119. doi: 10.14744/hf.2021.2021.0019 Q32.12025
De novo hepatitis B surface antigen (HBsAg)-positive, core antibody (anti-HBc)-negative, hepatitis B virus infection post-liver transplant from an anti-HBc, HBsAg-negative donor
肝移植术后新发单纯乙型肝炎核心抗体阳性，乙肝表面抗原阳性的乙型肝炎病毒感染病例（供者为HBsAg阴性，单纯抗-HBc阳性） 翻译改进
Harjot K Bedi 1, Roberto Trasolini 1 2, Christopher F Lowe 3, Trana Hussaini 4, Mark Bigham 5, Gordon Ritchie 3, Eric M Yoshida 1 2
作者单位 +展开
作者单位
DOI: 10.14744/hf.2021.2021.0019 PMID: 35784901
摘要 Ai翻译
相关内容
-
Inappropriate cessation of nucleos(t)ide analog associated with reduced liver transplant-free survival in patients with HBV-related acute on chronic liver failure
乙型肝炎相关急慢性重症肝炎患者中核苷(酸)类似物不恰当停用可降低免移植生存率
Hong Shi et al.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2021 Feb:134:111118.
-
Hepatitis B virus infection in liver transplant candidates and recipients
肝脏移植供体和受体的乙型肝炎病毒感染
Patrick Yachimski
MedGenMed : Medscape general medicine. 2005 Apr 18;7(2):20.
-
Prevention of hepatitis B virus reinfection in liver transplant recipients
肝移植受者的乙型肝炎病毒再感染的预防措施
Bruno Roche
Intervirology. 2014;57(3-4):196-201.
-
Prophylaxis of recurrent hepatitis B virus by vaccination after liver transplant: preliminary results
肝移植后用疫苗预防乙型肝炎病毒复发的试验及其初步结果
E Albeniz Arbizu et al.
Transplantation proceedings. 2003 Aug;35(5):1848-9.
-
Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis
接受乙肝免疫球蛋白预防仍发生再感染的肝移植受者的乙型肝炎病毒S区突变研究
M G Ghany et al.
Hepatology (Baltimore, Md.). 1998 Jan;27(1):213-22.
-
Outcome of lamivudine resistant hepatitis B virus infection in liver transplant recipients in Singapore
拉米夫定耐药乙肝病毒在我国肝移植受者的结局研究
C T Wai
Gut. 2000 Nov;47(5):741.
-
Immunoglobulin, nucleos(t)ide analogues and hepatitis B virus recurrence after liver transplant: A meta-analysis
免疫球蛋白和核苷(酸)类似物对肝移植后乙型肝炎病毒复发的影响：一项meta分析研究
Quirino Lai et al.
European journal of clinical investigation. 2021 Aug;51(8):e13575.
-
Complete hepatitis B virus prophylaxis withdrawal in hepatitis B surface antigen-positive liver transplant recipients after longterm minimal immunosuppression
长期低免疫抑制后乙型肝炎表面抗原阳性受者肝移植患者的乙肝停药阻断试验研究
Ilaria Lenci et al.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 2016 Sep;22(9):1205-13.
引文链接
复制
已复制！
推荐内容
De novo hepatitis B surface antigen (HBsAg)-positive, core antibody (anti-HBc)-negative, hepatitis B virus infection post-liver transplant from an anti-HBc, HBsAg-negative donor